The results of imatinib therapy for patients with primary eosinophilic disorders
- 11 April 2006
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 76 (6), 535-536
- https://doi.org/10.1111/j.1600-0609.2006.00652.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Modern Diagnosis and Treatment of Primary EosinophiliaActa Haematologica, 2005
- FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophiliaBlood, 2004
- Heterogeneity of Response to Imatinib-Mesylate (Glivec) in Patients with Hypereosinophilic Syndrome: Implications for Dosing and PathogenesisLeukemia & Lymphoma, 2004
- Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndromeBlood, 2004
- A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic SyndromeNew England Journal of Medicine, 2003
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975